Atlas Trials

Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Clinical trial NCT00653250 · COMPLETED

Trial details

NCT number
NCT00653250
Sponsor
Vanderbilt-Ingram Cancer Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Lung Cancer
Start date
2000-12-01
Primary completion
2006-03-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.